Skip to content
  • Sunday, 26 July 2026
  • 3:05 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery
Laboratory Automation & Robotics

Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery

Lana Keisha May 11, 2026 0

In a remarkable breakthrough in ocular pharmacology, researchers in China have pioneered the development of novel eye drops derived from…

Read More
Laboratory Automation & Robotics

Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery

Lana Keisha May 3, 2026 0

Researchers in China have achieved a significant breakthrough in ophthalmic pharmacology, developing innovative eye drops derived from pig semen that…

Read More
Laboratory Automation & Robotics

Revolutionary Eye Drops Derived from Pig Semen Show Promise for Non-Invasive Ocular Cancer Treatment

Lana Keisha Apr 26, 2026 0

A groundbreaking study published in Science Advances reveals that researchers in China have successfully engineered eye drops utilizing exosomes derived…

Read More
Laboratory Automation & Robotics

Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery

Lana Keisha Apr 16, 2026 0

Chinese researchers have unveiled a groundbreaking approach to treating ocular cancers, specifically retinoblastoma, through the development of specialized eye drops…

Read More
Laboratory Automation & Robotics

Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery

Lana Keisha Apr 9, 2026 0

Researchers in China have achieved a significant breakthrough in ophthalmic pharmacology, developing innovative eye drops derived from pig semen that…

Read More
Laboratory Automation & Robotics

Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery

Lana Keisha Apr 2, 2026 0

In a groundbreaking development that could revolutionize the treatment of ocular cancers, researchers in China have successfully engineered eye drops…

Read More
Here’s Why WebMCP is ExcitingBiopharma M&A Surges as Billion-Dollar Deals Fuel Pipeline Replenishment Amidst Patent Cliff PressuresExotic Matter in the Depths: New Superionic State of Carbon Hydride Discovered in Ice Giant SimulationsUnraveling the Secrets of Peroxisome Growth: Plant Research Illuminates Human Health and Bioengineering Potential
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ